This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gutsmann, T.
Right arrow Articles by Seydel, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gutsmann, T.
Right arrow Articles by Seydel, U.

 Previous Article  |  Next Article 

Infection and Immunity, November 2001, p. 6942-6950, Vol. 69, No. 11
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.11.6942-6950.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Dual Role of Lipopolysaccharide (LPS)-Binding Protein in Neutralization of LPS and Enhancement of LPS-Induced Activation of Mononuclear Cells

Thomas Gutsmann,1 Mareike Müller,1 Stephen F. Carroll,2 Roger C. MacKenzie,3 Andre Wiese,1 and Ulrich Seydel1,*

Department of Immunochemistry and Biochemical Microbiology, Center for Medicine and Biosciences, Research Center Borstel, D-23845 Borstel, Germany1; XOMA (US) LLC, Berkeley, California 947102; and Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ontario, Canada K1A OR63

Received 26 April 2001/Returned for modification 2 August 2001/Accepted 20 August 2001

The lipopolysaccharide (LPS)-binding protein (LBP) has a concentration-dependent dual role in the pathogenesis of gram-negative sepsis: low concentrations of LBP enhance the LPS-induced activation of mononuclear cells (MNC), whereas the acute-phase rise in LBP concentrations inhibits LPS-induced cellular stimulation. In stimulation experiments, we have found that LBP mediates the LPS-induced cytokine release from MNC even under serum-free conditions. In biophysical experiments we demonstrated that LBP binds and intercalates into lipid membranes, amplified by negative charges of the latter, and that intercalated LBP can mediate the CD14-independent intercalation of LPS into membranes in a lipid-specific and temperature-dependent manner. In contrast, prior complexation of LBP and LPS inhibited binding of these complexes to membranes due to different binding of LBP to LPS or phospholipids. This results in a neutralization of LPS and, therefore, to a reduced production of tumor necrosis factor by MNC. We propose that LBP is not only present as a soluble protein in the serum but may also be incorporated as a transmembrane protein in the cytoplasmic membrane of MNC and that the interaction of LPS with membrane-associated LBP may be an important step in LBP-mediated activation of MNC, whereas LBP-LPS complexation in the serum leads to a neutralization of LPS.


* Corresponding author. Mailing address: Research Center Borstel, Center for Medicine and Biosciences, Department of Immunochemistry and Biochemical Microbiology, Parkallee 10, D-23845 Borstel, Germany. Phone: 49 (0) 4537 188-232. Fax: 49 (0) 4537 188-632. E-mail: useydel{at}fz-borstel.de.


Infection and Immunity, November 2001, p. 6942-6950, Vol. 69, No. 11
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.11.6942-6950.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Minter, R. M., Bi, X., Ben-Josef, G., Wang, T., Hu, B., Arbabi, S., Hemmila, M. R., Wang, S. C., Remick, D. G., Su, G. L. (2009). LPS-binding protein mediates LPS-induced liver injury and mortality in the setting of biliary obstruction. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G45-G54 [Abstract] [Full Text]  
  • Lepper, P. M., Schumann, C., Triantafilou, K., Rasche, F. M., Schuster, T., Frank, H., Schneider, E. M., Triantafilou, M., von Eynatten, M. (2007). Association of Lipopolysaccharide-Binding Protein and Coronary Artery Disease in Men. J Am Coll Cardiol 50: 25-31 [Abstract] [Full Text]  
  • Schromm, A. B., Howe, J., Ulmer, A. J., Wiesmuller, K.-H., Seyberth, T., Jung, G., Rossle, M., Koch, M. H. J., Gutsmann, T., Brandenburg, K. (2007). Physicochemical and Biological Analysis of Synthetic Bacterial Lipopeptides: VALIDITY OF THE CONCEPT OF ENDOTOXIC CONFORMATION. J. Biol. Chem. 282: 11030-11037 [Abstract] [Full Text]  
  • Mueller, M., Stamme, C., Draing, C., Hartung, T., Seydel, U., Schromm, A. B. (2006). Cell Activation of Human Macrophages by Lipoteichoic Acid Is Strongly Attenuated by Lipopolysaccharide-binding Protein. J. Biol. Chem. 281: 31448-31456 [Abstract] [Full Text]  
  • Andra, J., Gutsmann, T., Garidel, P., Brandenburg, K. (2006). Invited review: Mechanisms of endotoxin neutralization by synthetic cationic compounds. Innate Immunity 12: 261-277 [Abstract]  
  • Papavlassopoulos, M., Stamme, C., Thon, L., Adam, D., Hillemann, D., Seydel, U., Schromm, A. B. (2006). MaxiK Blockade Selectively Inhibits the Lipopolysaccharide-Induced I{kappa}B-{alpha}/NF-{kappa}B Signaling Pathway in Macrophages. J. Immunol. 177: 4086-4093 [Abstract] [Full Text]  
  • Lehnert, M., Uehara, T., Bradford, B. U., Lind, H., Zhong, Z., Brenner, D. A., Marzi, I., Lemasters, J. J. (2006). Lipopolysaccharide-binding protein modulates hepatic damage and the inflammatory response after hemorrhagic shock and resuscitation. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G456-G463 [Abstract] [Full Text]  
  • Roes, S., Mumm, F., Seydel, U., Gutsmann, T. (2006). Localization of the Lipopolysaccharide-binding Protein in Phospholipid Membranes by Atomic Force Microscopy. J. Biol. Chem. 281: 2757-2763 [Abstract] [Full Text]  
  • Satoh, M., Iwahori, T., Sugawara, N., Yamazaki, M. (2006). Liver argininosuccinate synthase binds to bacterial lipopolysaccharides and lipid A and inactivates their biological activities. Innate Immunity 12: 21-38 [Abstract]  
  • Mueller, M., Lindner, B., Dedrick, R., Schromm, A.B., Seydel, U. (2005). Endotoxin: physical requirements for cell activation. Innate Immunity 11: 299-303 [Abstract]  
  • Schroder, N. W.J., Schumann, R. R. (2005). Non-LPS targets and actions of LPS binding protein (LBP). Innate Immunity 11: 237-242 [Abstract]  
  • Munford, R. S. (2005). Invited review: Detoxifying endotoxin: time, place and person. Innate Immunity 11: 69-84 [Abstract]  
  • Heinzelmann, M., Bosshart, H. (2005). Heparin Binds to Lipopolysaccharide (LPS)-Binding Protein, Facilitates the Transfer of LPS to CD14, and Enhances LPS-Induced Activation of Peripheral Blood Monocytes. J. Immunol. 174: 2280-2287 [Abstract] [Full Text]  
  • Mueller, M., Brandenburg, K., Dedrick, R., Schromm, A. B., Seydel, U. (2005). Phospholipids Inhibit Lipopolysaccharide (LPS)-Induced Cell Activation: A Role for LPS-Binding Protein. J. Immunol. 174: 1091-1096 [Abstract] [Full Text]  
  • Stoll, L. L., Denning, G. M., Li, W.-G., Rice, J. B., Harrelson, A. L., Romig, S. A., Gunnlaugsson, S. T., Miller, F. J. Jr, Weintraub, N. L. (2004). Regulation of Endotoxin-Induced Proinflammatory Activation in Human Coronary Artery Cells: Expression of Functional Membrane-Bound CD14 by Human Coronary Artery Smooth Muscle Cells. J. Immunol. 173: 1336-1343 [Abstract] [Full Text]  
  • Mueller, M., Lindner, B., Kusumoto, S., Fukase, K., Schromm, A. B., Seydel, U. (2004). Aggregates Are the Biologically Active Units of Endotoxin. J. Biol. Chem. 279: 26307-26313 [Abstract] [Full Text]  
  • Antonicelli, F., Brown, D., Parmentier, M., Drost, E. M., Hirani, N., Rahman, I., Donaldson, K., MacNee, W. (2004). Regulation of LPS-mediated inflammation in vivo and in vitro by the thiol antioxidant Nacystelyn. Am. J. Physiol. Lung Cell. Mol. Physiol. 286: L1319-L1327 [Abstract] [Full Text]  
  • Kato, A., Ogasawara, T., Homma, T., Saito, H., Matsumoto, K. (2004). Lipopolysaccharide-Binding Protein Critically Regulates Lipopolysaccharide-Induced IFN-{beta} Signaling Pathway in Human Monocytes. J. Immunol. 172: 6185-6194 [Abstract] [Full Text]  
  • Brandenburg, K., Garidel, P., Andra, J., Jurgens, G., Muller, M., Blume, A., Koch, M. H. J., Levin, J. (2003). Cross-linked Hemoglobin Converts Endotoxically Inactive Pentaacyl Endotoxins into a Physiologically Active Conformation. J. Biol. Chem. 278: 47660-47669 [Abstract] [Full Text]  
  • Thompson, P. A., Tobias, P. S., Viriyakosol, S., Kirkland, T. N., Kitchens, R. L. (2003). Lipopolysaccharide (LPS)-binding Protein Inhibits Responses to Cell-bound LPS. J. Biol. Chem. 278: 28367-28371 [Abstract] [Full Text]  
  • Muller, M., Scheel, O., Lindner, B., Gutsmann, T., Seydel, U. (2003). The role of membrane-bound LBP, endotoxin aggregates, and the MaxiK channel in LPS-induced cell activation. Innate Immunity 9: 181-186 [Abstract]  
  • Wiese, A., Gutsmann, T., Seydel, U. (2003). Review: Towards antibacterial strategies: studies on the mechanisms of interaction between antibacterial peptides and model membranes. Innate Immunity 9: 67-84 [Abstract]  
  • Stamme, C., Muller, M., Hamann, L., Gutsmann, T., Seydel, U. (2002). Surfactant Protein A Inhibits Lipopolysaccharide-Induced Immune Cell Activation by Preventing the Interaction of Lipopolysaccharide with Lipopolysaccharide-Binding Protein. Am. J. Respir. Cell Mol. Bio. 27: 353-360 [Abstract] [Full Text]  
  • Fierer, J., Swancutt, M. A., Heumann, D., Golenbock, D. (2002). The Role of Lipopolysaccharide Binding Protein in Resistance to Salmonella Infections in Mice. J. Immunol. 168: 6396-6403 [Abstract] [Full Text]